Skip to main content
Loading

Ocugen

Monday, February 26, 2024
Plymouth
Gene/Cell Therapy
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patient’s lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs.
Speakers
Shankar Musunuri, Chairman, CEO, Co-founder - Ocugen, Inc.

State

Pennsylvania

Country

United States

Website

https://ocugen.com/

CEO/Top Company Official

Dr. Shankar Musunuri

Lead Product in Development

OCU400

Development Phase of Primary Product

Phase II
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Media Partner


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP